Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

First European Commission approval of a bispecific antibody discovered using OmniAb OmniAb, Inc. is eligible to receive a $10 million milestone upon first commercial sale in Europe EMERYVILLE, Calif.–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that the Janssen Biotech, Inc. (Janssen) received conditional marketing authorization (CMA) from the European Commission for TECVAYLI® (teclistamab) as monotherapy … [Read more…]

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

TEANECK, N.J.–(BUSINESS WIRE)–Phibro Animal Health Corporation (Nasdaq:PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided financial guidance for the year ending June 30, 2023. Highlights for the three months ended June 30, 2022 (compared to the three months ended June 30, 2021) … [Read more…]

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in the following upcoming investor conferences: Citi 17th Annual BioPharma Conference Date: Wednesday, September 7th, 2022 Location: Boston, MA Format: 1-on-1 meetings only Morgan Stanley 20th … [Read more…]

Alnylam Announces Appointment of Elliott Sigal, M.D., Ph.D., to Board of Directors

– Dr. Sigal Brings Decades of Leadership Experience at Biopharmaceutical Companies – – Served as Chief Scientific Officer and a Director of Bristol-Myers Squibb – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) the leading RNAi therapeutics company, announced today the appointment of Elliott Sigal, M.D., Ph.D., to its Board of Directors. Dr. Sigal brings decades … [Read more…]

Smart & Final Charitable Foundation Announces Annual Fundraising Campaign to Benefit Kids 4 Hope

Now Through September 6, Customers Can Support City of Hope’s Pediatric Cancer Program at all Smart & Final Locations LOS ANGELES–(BUSINESS WIRE)–#MySmartandFinal—Smart & Final, the smaller, faster grocery warehouse store for household and business customers, is holding its annual fundraiser benefiting City of Hope’s Kids 4 Hope program. A world-renowned independent research center, City of … [Read more…]

Pop-in Care, a Parentis Health Company, Introduces New Pricing to Provide Greater Flexibility and Value for Care of Seniors, Individuals with Disabilities or People Recovering from Surgery

LAGUNA HILLS, Calif. & ORANGE COUNTY, Calif.–(BUSINESS WIRE)–#AcuteRecoveryCare—Pop-in Care, a Parentis Health subsidiary company, has introduced a new pricing structure for its licensed in-home care services catering to individuals with disabilities, the elderly, and those recovering from surgeries or other acute illnesses. Pop-in Care continues to maintain its emphasis on short visits, without minimum hourly … [Read more…]

Oticon Introduces World’s Smallest Hearing Aid with BrainHearing™ Technology

Fully Customized Lineup of In-the-Ear Hearing Aid Solutions Designed for a Discreet & Personalized Listening Experience SOMERSET, N.J.–(BUSINESS WIRE)–#Oticon–Hearing aid manufacturer Oticon, Inc. is launching Oticon Own™, a new family of custom hearing aids. Developed for ultimate discreetness and superior sound quality, Oticon Own is a fully customized in-the-ear hearing solution. Harnessing the power of … [Read more…]

CANbridge Announces Financial Results and Corporate Updates for Six Months Ended June 30, 2022

BEIJING & BURLINGTON, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (“CANbridge,” 1228.HK), a China and U.S.-based global biopharmaceutical company committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, today announced financial results for the six months ended 2022 and a corporate update. “We have made significant progress over the first half … [Read more…]

Global Veterinary X-Ray Market Report 2022-2027: Rapid Technological Advancements in Animal Healthcare to Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Veterinary X-Ray Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. The rapid technological advancements in animal healthcare are expected to fuel the growth of the global veterinary X-ray market. The sector is being driven by technological advancements in animal healthcare, such as effective assimilation of radiology … [Read more…]

One Mind Announces the Winners of the 2022 Rising Star Awards for Mental Health Research

$900,000 will be awarded to three emerging leaders pursuing innovative research to benefit people living with mental health conditions RUTHERFORD, Calif.–(BUSINESS WIRE)–One Mind™, in collaboration with COMPASS Pathways plc, has announced the recipients of three “2022 One Mind – COMPASS Rising Stars Awards”. Each awardee will receive a $300,000 grant over a three year-period and … [Read more…]